secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2026-07-29T21:02:11+00:00
Accession:  0001213900-26-082879
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Onconetix raises $30.25M via Series F convertible preferred and enters $750M ELOC facility
--------------------------------------------------------------------------------

- Issued 37,812 shares of Series F convertible preferred stock at $1,000 stated value for $30.25M aggregate purchase price.
- Series F convertible into common stock at $0.9767 per share, subject to anti-dilution adjustments and beneficial ownership limitation of 4.99%.
- Entered into ELOC purchase agreement for up to $750M (or 19.99% of outstanding shares) with $30M commitment fee applied to PIPE.
- Registration rights agreements filed for resale of conversion shares and ELOC shares; penalties for failure to register.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390026082879/0001213900-26-082879-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390026082879/ea0299510-8k_onconetix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-082879

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer